
Kigali facility revs up Africa’s vaccine self-reliance
A new European financial backing of BioNTech’s mRNA vaccine facility in Kigali marks a defining step in Africa’s long-term pursuit of health and industrial self-reliance, moving the continent’s vaccine manufacturing ambitions from concept to implementation.


